Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients - PubMed (original) (raw)
Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients
Jann-Tay Wang et al. Emerg Infect Dis. 2004 May.
Abstract
Clinical and laboratory data on severe acute respiratory syndrome (SARS), particularly on the temporal progression of abnormal laboratory findings, are limited. We conducted a prospective study on the clinical, radiologic, and hematologic findings of SARS patients with pneumonia, who were admitted to National Taiwan University Hospital from March 8 to June 15, 2003. Fever was the most frequent initial symptom, followed by cough, myalgia, dyspnea, and diarrhea. Twenty-four patients had various underlying diseases. Most patients had elevated C-reactive protein (CRP) levels and lymphopenia. Other common abnormal laboratory findings included leukopenia, thrombocytopenia, and elevated levels of aminotransferase, lactate dehydrogenase, and creatine kinase. These clinical and laboratory findings were exacerbated in most patients during the second week of disease. The overall case-fatality rate was 19.7%. By multivariate analysis, underlying disease and initial CRP level were predictive of death.
Figures
Figure
The time relationships between the time points of defervescence, initiation of steroid, and when chest radiographic finding as well as various laboratory parameters became most severe. Mean and standard deviation (days) are presented. CXR, chest radiography; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; CRP, C-reactive protein; CK, creatine kinase.
Similar articles
- Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever.
Liu CL, Lu YT, Peng MJ, Chen PJ, Lin RL, Wu CL, Kuo HT. Liu CL, et al. Chest. 2004 Aug;126(2):509-17. doi: 10.1378/chest.126.2.509. Chest. 2004. PMID: 15302738 Free PMC article. - Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P, Ephtimios IE, Kitai I, Mederski BD, Shadowitz SB, Gold WL, Hawryluck LA, Rea E, Chenkin JS, Cescon DW, Poutanen SM, Detsky AS. Booth CM, et al. JAMA. 2003 Jun 4;289(21):2801-9. doi: 10.1001/jama.289.21.JOC30885. Epub 2003 May 6. JAMA. 2003. PMID: 12734147 - Preliminary clinical description of severe acute respiratory syndrome.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2003 Mar 28;52(12):255-6. MMWR Morb Mortal Wkly Rep. 2003. PMID: 12680522 - Severe acute respiratory syndrome.
Wang JT, Chang SC. Wang JT, et al. Curr Opin Infect Dis. 2004 Apr;17(2):143-8. doi: 10.1097/00001432-200404000-00013. Curr Opin Infect Dis. 2004. PMID: 15021055 Review. - Severe acute respiratory syndrome (SARS): epidemiology and clinical features.
Hui DS, Chan MC, Wu AK, Ng PC. Hui DS, et al. Postgrad Med J. 2004 Jul;80(945):373-81. doi: 10.1136/pgmj.2004.020263. Postgrad Med J. 2004. PMID: 15254300 Free PMC article. Review.
Cited by
- Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study.
Shao Z, Feng Y, Zhong L, Xie Q, Lei M, Liu Z, Wang C, Ji J, Liu H, Gu Z, Hu Z, Su L, Wu M, Liu Z. Shao Z, et al. Clin Transl Immunology. 2020 Oct 14;9(10):e1192. doi: 10.1002/cti2.1192. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33082954 Free PMC article. - Clinical course and findings of 14 patients with COVID-19 compared with 5 patients with conventional human coronavirus pneumonia.
Ishiguro T, Takano K, Kagiyama N, Hosoda C, Kobayashi Y, Takaku Y, Takata N, Ueda M, Morimoto Y, Kasuga K, Ozawa R, Isono T, Nishida T, Kawate E, Kobayashi Y, Shimizu Y, Kurashima K, Yanagisawa T, Takayanagi N. Ishiguro T, et al. Respir Med Case Rep. 2020;31:101207. doi: 10.1016/j.rmcr.2020.101207. Epub 2020 Aug 27. Respir Med Case Rep. 2020. PMID: 32874906 Free PMC article. - Potential neurological manifestations of COVID-19: a narrative review.
Pergolizzi JV Jr, Raffa RB, Varrassi G, Magnusson P, LeQuang JA, Paladini A, Taylor R, Wollmuth C, Breve F, Chopra M, Nalamasu R, Christo PJ; NEMA Research Group. Pergolizzi JV Jr, et al. Postgrad Med. 2022 May;134(4):395-405. doi: 10.1080/00325481.2020.1837503. Epub 2021 Jan 11. Postgrad Med. 2022. PMID: 33089707 Free PMC article. Review. - Evaluation of the Hospitalized Coronavirus Disease 2019 Patients in First 3 Months of the Pandemic.
Alkan S, Akça A, Şener A, Doğan E, Gönlügür U, Şimşek T, Özer Ş, Yüksel B, Öz K, Kurt K. Alkan S, et al. Turk Thorac J. 2022 Jan;23(1):52-57. doi: 10.5152/TurkThoracJ.2022.21118. Turk Thorac J. 2022. PMID: 35110201 Free PMC article. - SARS, MERS and CoVID-19: An overview and comparison of clinical, laboratory and radiological features.
Pustake M, Tambolkar I, Giri P, Gandhi C. Pustake M, et al. J Family Med Prim Care. 2022 Jan;11(1):10-17. doi: 10.4103/jfmpc.jfmpc_839_21. Epub 2022 Jan 31. J Family Med Prim Care. 2022. PMID: 35309670 Free PMC article. Review.
References
- World Health Organization. SARS epidemiology to date [monograph on the Internet]. 2003. [cited April 11, 2003]. Available from: http://www.who.int/csr/sars/epi2003_04_11/en/
- World Health Organization. Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS) [monograph on the Internet]. [cited July 11, 2003]. Available from: http://www.who.int/csr/sars/country/en
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous